NASDAQ$QSI
Quantum-Si Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Quantum-Si reported financial results for the third quarter ended September 30, 2024.
Quantum-Si reported revenue of $787,000 for the third quarter of 2024. The company is focusing on commercial execution and innovation, with new kits on track for launch in Q4. They anticipate not achieving their full year guided revenue range of $3.7 million to $4.2 million.
- Reported revenue of $787,000 for the third quarter of 2024.
- Liberate Bio integrated Platinum® Next-Generation Sequencing into their platform.
- Todd Bennett appointed as Chief Commercial Officer, John Vieceli, Ph.D. as Chief Product Officer and Lindsay Thompson as Chief Human Resources Officer.
- New library preparation kit and barcoding kit remain on track for launch before year end.
Headline financials
Revenue & EPS history
Quantum-Si · Revenue · Quarterly
$787K
Forward guidance
Quantum-Si provided updated full year 2024 financial guidance for adjusted operating expenses and cash usage.
Tailwinds
- Adjusted total operating expenses approximately $100 million.
- Total cash usage approximately $92 million.
- Cash runway into the second half of 2026.
- Focus on commercial execution.
- New kits expected to drive broader market adoption.
Headwinds
- Potential shortfall in achieving full year guided revenue range of $3.7 million to $4.2 million.
- Observed some lengthening of the sales cycle in the third quarter.
- Uncertainties related to future performance and development.
- Risks related to commercialization of products and services.
- Competition with other companies in the proteomic analysis market.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
-4.1%
Avg return
Earnings day
-4.3%
Avg return
5 days after
+1.5%
Avg return
30 days after
39%
9 / 23 earnings
Positive
+14.5%
Q3 2023
Best reaction
-39.5%
Q2 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -4.5% | -8.3% | +1.0% | |
| Q4 2025 | -4.3% | -2.3% | -21.1% | |
| Q3 2025 | -8.5% | -12.2% | -20.0% | |
| Q1 2025 | +0.0% | -0.3% | +12.2% | |
| Q4 2024 | +6.2% | -0.8% | -10.8% | |
| Q3 2024 | -20.8% | -26.6% | +81.0% | |
| Q2 2024 | -2.8% | -4.8% | +4.5% | |
| Q1 2024 | -5.6% | +1.7% | -17.8% | |
| Q4 2023 | +6.3% | -7.5% | +13.2% | |
| Q3 2023 | +14.5% | +29.0% | +26.6% | |
| Q2 2023 | -39.5% | -34.8% | -31.9% | |
| Q1 2023 | -13.5% | -15.3% | -1.8% | |
| Q4 2022 | -12.5% | -26.4% | -27.8% | |
| Q3 2022 | +3.2% | +26.8% | -7.6% | |
| Q2 2022 | -6.0% | +9.7% | -14.4% | |
| Q1 2022 | -14.9% | -9.1% | +3.0% | |
| Q4 2019 | +6.2% | -3.8% | +12.5% | |
| Q4 2021 | +6.8% | -9.5% | +13.1% | |
| Q3 2021 | +1.2% | +1.4% | -21.5% | |
| Q2 2021 | +1.9% | +4.4% | +14.2% | |
| Q2 2020 | +1.9% | +4.4% | +14.2% | |
| Q1 2021 | -7.6% | -18.7% | +28.5% | |
| Q4 2020 | -1.1% | +5.0% | -13.8% | |
| Q3 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro